Artificial intelligence (AI) is transforming industries, including the life sciences industry, from drug discovery and diagnostics to medical devices and manufacturing. With that transformation comes a critical challenge: crafting strategies to protect AI-related innovations. Strategies for protecting AI innovations are unique. Approaching IP protections for AI innovations in the same way as approaching IP protections for traditional biotech, diagnostic, or medical innovations is likely to lead to failure and frustration. Understanding the legal framework for AI innovations, how it applies in practice, and what strategies improve the odds of obtaining protection is essential for any company innovating with AI.
Paige Reese
Paige prepares and prosecutes patent applications, conducts patentability and freedom to operate searches, counsels clients on the strategic use of intellectual property assets, and drafts and negotiates the complex agreements that underpin software development and licensing. She also provides counsel on general corporate matters and mergers and acquisitions, especially those with intellectual property implications. While Paige works with clients in a variety of industries, she holds a degree in computer science and has a particular focus on technology, software, new IT processes, and machine learning.